These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 23656966)
1. Credibility and comprehension of healthy volunteers in lengthy inpatient drug studies. Apseloff G; Kitzmiller JP; Tishler CL Am J Ther; 2013; 20(3):257-60. PubMed ID: 23656966 [TBL] [Abstract][Full Text] [Related]
2. Understanding the decisions of cancer clinical trial participants to enter research studies: factors associated with informed consent, patient satisfaction, and decisional regret. Stryker JE; Wray RJ; Emmons KM; Winer E; Demetri G Patient Educ Couns; 2006 Oct; 63(1-2):104-9. PubMed ID: 16242898 [TBL] [Abstract][Full Text] [Related]
3. Factors related to volunteer comprehension of informed consent for a clinical trial. Kaewpoonsri N; Okanurak K; Kitayaporn D; Kaewkungwal J; Vijaykadga S; Thamaree S Southeast Asian J Trop Med Public Health; 2006 Sep; 37(5):996-1004. PubMed ID: 17333746 [TBL] [Abstract][Full Text] [Related]
4. What do our patients understand about their trial participation? Assessing patients' understanding of their informed consent consultation about randomised clinical trials. Behrendt C; Gölz T; Roesler C; Bertz H; Wünsch A J Med Ethics; 2011 Feb; 37(2):74-80. PubMed ID: 21098797 [TBL] [Abstract][Full Text] [Related]
5. Comprehension and recall from the informed consent process by phase I healthy volunteers before dose administration. Tadros R; Caughey GE; Johns S; Shakib S Clin Trials; 2019 Jun; 16(3):283-289. PubMed ID: 30818994 [TBL] [Abstract][Full Text] [Related]
6. Recall of informed consent information by healthy volunteers in clinical trials. Fortun P; West J; Chalkley L; Shonde A; Hawkey C QJM; 2008 Aug; 101(8):625-9. PubMed ID: 18487271 [TBL] [Abstract][Full Text] [Related]
7. Healthy participants in phase I clinical trials: the quality of their decision to take part. Rabin C; Tabak N J Clin Nurs; 2006 Aug; 15(8):971-9. PubMed ID: 16879541 [TBL] [Abstract][Full Text] [Related]
8. Healthy volunteers' perceptions of risk in US Phase I clinical trials: A mixed-methods study. Fisher JA; McManus L; Cottingham MD; Kalbaugh JM; Wood MM; Monahan T; Walker RL PLoS Med; 2018 Nov; 15(11):e1002698. PubMed ID: 30457992 [TBL] [Abstract][Full Text] [Related]
9. The views of patients and healthy volunteers on participation in clinical trials: an exploratory survey study. Chu SH; Jeong SH; Kim EJ; Park MS; Park K; Nam M; Shim JY; Yoon YR Contemp Clin Trials; 2012 Jul; 33(4):611-9. PubMed ID: 22405971 [TBL] [Abstract][Full Text] [Related]
10. The impact of disease severity on the informed consent process in clinical research. Schaeffer MH; Krantz DS; Wichman A; Masur H; Reed E; Vinicky JK Am J Med; 1996 Mar; 100(3):261-8. PubMed ID: 8629670 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the ability of clinical research participants to comprehend informed consent form. Bhansali S; Shafiq N; Malhotra S; Pandhi P; Singh I; Venkateshan SP; Siddhu S; Sharma YP; Talwar KK Contemp Clin Trials; 2009 Sep; 30(5):427-30. PubMed ID: 19341820 [TBL] [Abstract][Full Text] [Related]
12. Medical eligibility, comprehension of the consent process, and retention of injection drug users recruited for an HIV vaccine trial. Harrison K; Vlahov D; Jones K; Charron K; Clements ML J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):386-90. PubMed ID: 7552502 [TBL] [Abstract][Full Text] [Related]
13. Improvement of the comprehension of written information given to healthy volunteers in biomedical research: a single-blind randomized controlled study. Paris A; Nogueira da Gama Chaves D; Cornu C; Maison P; Salvat-Mélis M; Ribuot C; Brandt C; Bosson JL; Hommel M; Cracowski JL Fundam Clin Pharmacol; 2007 Apr; 21(2):207-14. PubMed ID: 17391294 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic misconception in early phase gene transfer trials. Henderson GE; Easter MM; Zimmer C; King NM; Davis AM; Rothschild BB; Churchill LR; Wilfond BS; Nelson DK Soc Sci Med; 2006 Jan; 62(1):239-53. PubMed ID: 16000230 [TBL] [Abstract][Full Text] [Related]
15. The problem with optimism in clinical trials. Jansen LA IRB; 2006; 28(4):13-9. PubMed ID: 17036434 [No Abstract] [Full Text] [Related]
16. Development of tool for the assessment of comprehension of informed consent form in healthy volunteers participating in first-in-human studies. Arora A; Rajagopalan S; Shafiq N; Pandhi P; Bhalla A; Dhibar DP; Malhotra S Contemp Clin Trials; 2011 Nov; 32(6):814-7. PubMed ID: 21664491 [TBL] [Abstract][Full Text] [Related]
17. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 7: Informed consent and xenotransplantation clinical trials. Vanderpool HY Xenotransplantation; 2009; 16(4):255-62. PubMed ID: 19799766 [TBL] [Abstract][Full Text] [Related]
18. Are subjects satisfied with the informed consent process? A survey of research participants. Pope JE; Tingey DP; Arnold JM; Hong P; Ouimet JM; Krizova A J Rheumatol; 2003 Apr; 30(4):815-24. PubMed ID: 12672205 [TBL] [Abstract][Full Text] [Related]
19. A new brief instrument for assessing decisional capacity for clinical research. Jeste DV; Palmer BW; Appelbaum PS; Golshan S; Glorioso D; Dunn LB; Kim K; Meeks T; Kraemer HC Arch Gen Psychiatry; 2007 Aug; 64(8):966-74. PubMed ID: 17679641 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic misconception and the appreciation of risks in clinical trials. Lidz CW; Appelbaum PS; Grisso T; Renaud M Soc Sci Med; 2004 May; 58(9):1689-97. PubMed ID: 14990370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]